Showing results (281-290 of 382) with videos related to
Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.Cancer Immunology Research|August 6, 2016
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell CarcinomaMaria Libera Ascierto, Tracee L McMiller, Alan E Berger, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2004
Bacteriolytic therapy can generate a potent immune response against experimental tumorsNishant Agrawal, Chetan Bettegowda, Ian Cheong, et al.Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.International Journal of Radiation Oncology, Biology, Physics|September 26, 2013
Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer modelSatoshi Wada, Timothy J Harris, Erik Tryggestad, et al.Biorxiv : the Preprint Server for Biology|February 14, 2024
Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunityHong Yu, Hiroshi Nishio, Joseph Barbi, et al.Cancer Immunology Research|February 24, 2018
TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic TumorsBrian J Francica, Ali Ghasemzadeh, Anthony L Desbien, et al.The Prostate|February 26, 2021
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trialEugene Shenderov, Karim Boudadi, Wei Fu, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2014
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trialBora Gurel, M Scott Lucia, Ian M Thompson, et al.Communications Medicine|July 2, 2024
High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistanceYu-Hwa Huang, Charles H Yoon, Amit Gandhi, et al.Pageof 39